Visit to visit transition in TXNIP gene methylation and the risk of type 2 diabetes mellitus : a nested case-control study
© 2024. The Author(s), under exclusive licence to The Japan Society of Human Genetics..
Our study aimed to investigate the association between the transition of the TXNIP gene methylation level and the risk of incident type 2 diabetes mellitus (T2DM). This study included 263 incident cases of T2DM and 263 matched non-T2DM participants. According to the methylation levels of five loci (CpG1-5; chr1:145441102-145442001) on the TXNIP gene, the participants were classified into four transition groups: maintained low, low to high, high to low, and maintained high methylation levels. Compared with individuals whose methylation level of CpG2-5 at the TXNIP gene was maintained low, individuals with maintained high methylation levels showed a 61-87% reduction in T2DM risk (66% for CpG2 [OR: 0.34, 95% CI: 0.14, 0.80]; 77% for CpG3 [OR: 0.23, 95% CI: 0.07, 0.78]; 87% for CpG4 [OR: 0.13, 95% CI: 0.03, 0.56]; and 61% for CpG5 [OR: 0.39, 95% CI: 0.16, 0.92]). Maintained high methylation levels of four loci of the TXNIP gene are associated with a reduction of T2DM incident risk in the current study. Our study suggests that preserving hypermethylation levels of the TXNIP gene may hold promise as a potential preventive measure against the onset of T2DM.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Journal of human genetics - (2024) vom: 25. März |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wu, Yuying [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 26.03.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1038/s10038-024-01243-8 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370176073 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM370176073 | ||
003 | DE-627 | ||
005 | 20240327000610.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240327s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s10038-024-01243-8 |2 doi | |
028 | 5 | 2 | |a pubmed24n1349.xml |
035 | |a (DE-627)NLM370176073 | ||
035 | |a (NLM)38528048 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wu, Yuying |e verfasserin |4 aut | |
245 | 1 | 0 | |a Visit to visit transition in TXNIP gene methylation and the risk of type 2 diabetes mellitus |b a nested case-control study |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 26.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a © 2024. The Author(s), under exclusive licence to The Japan Society of Human Genetics. | ||
520 | |a Our study aimed to investigate the association between the transition of the TXNIP gene methylation level and the risk of incident type 2 diabetes mellitus (T2DM). This study included 263 incident cases of T2DM and 263 matched non-T2DM participants. According to the methylation levels of five loci (CpG1-5; chr1:145441102-145442001) on the TXNIP gene, the participants were classified into four transition groups: maintained low, low to high, high to low, and maintained high methylation levels. Compared with individuals whose methylation level of CpG2-5 at the TXNIP gene was maintained low, individuals with maintained high methylation levels showed a 61-87% reduction in T2DM risk (66% for CpG2 [OR: 0.34, 95% CI: 0.14, 0.80]; 77% for CpG3 [OR: 0.23, 95% CI: 0.07, 0.78]; 87% for CpG4 [OR: 0.13, 95% CI: 0.03, 0.56]; and 61% for CpG5 [OR: 0.39, 95% CI: 0.16, 0.92]). Maintained high methylation levels of four loci of the TXNIP gene are associated with a reduction of T2DM incident risk in the current study. Our study suggests that preserving hypermethylation levels of the TXNIP gene may hold promise as a potential preventive measure against the onset of T2DM | ||
650 | 4 | |a Journal Article | |
700 | 1 | |a Chen, Weiling |e verfasserin |4 aut | |
700 | 1 | |a Zhao, Yang |e verfasserin |4 aut | |
700 | 1 | |a Gu, Minqi |e verfasserin |4 aut | |
700 | 1 | |a Gao, Yajuan |e verfasserin |4 aut | |
700 | 1 | |a Ke, Yamin |e verfasserin |4 aut | |
700 | 1 | |a Wang, Longkang |e verfasserin |4 aut | |
700 | 1 | |a Wang, Mengmeng |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Wenkai |e verfasserin |4 aut | |
700 | 1 | |a Chen, Yaobing |e verfasserin |4 aut | |
700 | 1 | |a Huo, Weifeng |e verfasserin |4 aut | |
700 | 1 | |a Fu, Xueru |e verfasserin |4 aut | |
700 | 1 | |a Li, Xi |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Dongdong |e verfasserin |4 aut | |
700 | 1 | |a Qin, Pei |e verfasserin |4 aut | |
700 | 1 | |a Hu, Fulan |e verfasserin |4 aut | |
700 | 1 | |a Liu, Yu |e verfasserin |4 aut | |
700 | 1 | |a Sun, Xizhuo |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Ming |e verfasserin |4 aut | |
700 | 1 | |a Hu, Dongsheng |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of human genetics |d 1998 |g (2024) vom: 25. März |w (DE-627)NLM095504133 |x 1435-232X |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:25 |g month:03 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s10038-024-01243-8 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 25 |c 03 |